中国实用外科杂志

中国实用外科杂志

• 论著 • 上一篇    下一篇

经皮微波消融治疗极早期肝癌102例疗效分析

许    贇1，2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2，沈    强2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2，王    能2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2，吴盼盼1，2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2，许芸芸2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2，钱国军2[Author]) AND 1[Journal]) AND year[Order])" target="_blank">2   

  1. 1苏州大学研究生院，江苏苏州215000；2第二军医大学东方肝胆外科医院微创一科，上海200438
  • 出版日期:2015-09-01 发布日期:2015-08-28

  • Online:2015-09-01 Published:2015-08-28

摘要：

目的    评估经皮微波消融治疗极早期肝癌的疗效并行预后相关因素分析。方法    2007年1月至2012年1月，第二军医大学东方肝胆外科医院对收治的102例极早期肝癌病人行微波消融治疗,统计分析其完全消融率、总体存活率、无病存活率。结果    截至随访结束，全组肿瘤完全消融率96.1%，1、3、5年总体存活率和无瘤存活率分别为94.1%、84.3%、72.5%和90.2%、73.5%、59.2%。结论    经皮微波消融是治疗极早期肝癌安全、有效的方式。

关键词: 肝细胞肝癌, 微波消融, 超声引导

Abstract:

Percutaneous microwave ablation for very-early stage hepatocellular carcinoma        XU Yun*，SHEN Qiang，WANG Neng，et al. *Graduate School of Soochow University，Suzhou 215006，China
Corresponding author：QIAN Guo-jun，E-mail：qgjs@sina.com
Abstract    Objective    To investigate the effects and prognostic factors for the survival in the patients with very-early stage hepatocellular carcinoma (HCC) treated with percutaneous microwave ablation. Methods    From January 2007 to January 2012，102 cases of very-early stage HCC were treated by percutaneous microwave ablation. Complete ablation rate，overall survival rate，disease-free survival rate were observed and analyzed. Results The complete ablation rate was 96.1%. The 1-，3-，and 5-year overall survival ratet and corresponding disease-free survival rate was 94.1%, 84.3%, 72.5% and 90.2%, 73.5%, 59.2% respectively. Conclusion    Percutaneous microwave ablation is a safe and efficient therapy for very-early stage HCC.

Key words: hepatocellular carcinoma, microwave ablation, ultrasound-guided